Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections
- Substances:Mavorixafor
Portugal- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Mavorixafor
- Sponsor:X4 Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations
Back to Portugal44 clinical trials in Aveiro, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on cardiovascular conditions, including studies of new treatments for acute myocardial infarction and hypertrophic cardiomyopathy. Researchers are evaluating novel therapies for stroke prevention and heart-related complications.
Advanced studies targeting improved outcomes in patients with various cardiac conditions through innovative therapeutic approaches.
Research initiatives addressing chronic respiratory conditions, with particular emphasis on chronic rhinosinusitis and COPD. Studies are evaluating new therapeutic agents for managing symptoms and improving patient quality of life.
Comprehensive trials exploring both symptomatic relief and long-term disease modification strategies.
Clinical investigations into metabolic conditions, focusing on obesity, diabetes, and related complications. Studies are examining new treatments for hypertriglyceridemia and innovative approaches to weight management.
Groundbreaking research aimed at developing effective therapies for metabolic disorders and their associated complications.
Studies investigating treatments for blood disorders, particularly focusing on conditions like Paroxysmal Nocturnal Hemoglobinuria and various forms of neutropenia. Researchers are evaluating novel therapeutic approaches.
Innovative clinical trials exploring new treatment options for rare and chronic blood conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.